EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Effect of baseline long-acting muscarinic antagonist (LAMA) use on inhaled corticosteroid dose reduction in patients with severe eosinophilic asthma treated with benralizumab: SHAMAL post-hoc analysis

Friday 31 May, 08:58 AM - 09:05 AM Valencia, Spain